fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science.

Ionis and UCSD Collaborating to Fight Multiple Myeloma; Thermo Fisher Acquires Mesa Biotech for $550M; BlueNalu Completes $60M Funding Round

  • 2021-01-21T20:00:00.000+0000
  • California
  • Author: Lauren Panetta

1/21/21-Ultragenyx

Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Gene Therapy for the Treatment of Wilson Disease

1/20/21 – GenomeWeb

Bionano Genomics to Raise $200M in Public Stock Offering

1/20/21 – INOVIO Pharmaceuticals

INOVIO Announces Pricing of Public Offering of Common Stock

1/20/21 – GenomeWeb

Invitae to Raise $400M in Proposed Public Offering

1/20/21 – Genentech

FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone) for Unclassifiable Interstitial Lung Disease

1/20/21 – FierceBiotech

Ionis and UCSD take an antisense approach to fighting treatment-resistant multiple myeloma

1/19/21 – FierceBiotech

Thermo Fisher nets hand-held COVID-19 test maker Mesa Biotech with $550M deal

1/19/21 – SBP Discovery

New drug combination shows promise as powerful treatment for AML

1/19/21 – BridgeBio Pharma

Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.

1/19/21 – NeuCyte

NeuCyte and Mount Sinai Enter Collaboration Agreement

1/19/21 – Twist Bioscience

Twist Bioscience Signs Two Biopharma Technology Agreements to Enable Novel Therapeutics Discovery

1/19/21 – BlueNalu

BlueNalu Secures $60 Million in Convertible Note Financing

1/19/21 – FierceBiotech

Lilly gives $60M to Merus, ties in $1.6B in biobucks for next-gen cancer research pact

1/15/21 – Halozyme

Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis

1/15/21 – Arcus Biosciences

Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer

1/15/21 – 23andMe

Medscape study in collaboration with 23andMe finds Primary Care Physicians are increasingly more comfortable with direct-to-consumer genetic health testing

1/14/21 – Bio-IT World

10x Genomics’ Million Cell Platform, High Def Spatial Transcriptomics, More

1/14/21 – Mammoth Biosciences

Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms

1/13/21 – Pacific Biosciences of California

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform